Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07735819) titled 'Positron Emission Tomography/Computed Tomography (PET/CT) Imaging in Patients Diagnosed With a Glioma' on July 24.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
Primary Sponsor: Barbara Ann Karmanos Cancer Institute
Condition:
Low Grade Glioma
Glioblastoma
Intervention:
Drug: Minocycline 200mg/day
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: September 2026
Target Sample Size: 61
Countries of Recruitment:
United States
To know more, visit https://clinica...